The study demonstrates that activating the vitamin D receptor (VDR) with calcitriol suppresses cell proliferation in ...

November is Pulmonary Hypertension Awareness Month, and George Washington University Hospital’s Doctor Mardi Gomberg-Maitland ...

If you have pulmonary arterial hypertension (PAH), it’s possible ... and it gives off high-frequency sound waves to make pictures of your heart. The wand will have some gel on its end, which ...

Because pulmonary arterial hypertension (PAH) often causes shortness of breath, swelling, and fatigue, exercise may seem like the last thing you should do. But the right kind -- with your doctor ...

The Pulmonary Hypertension Association (PHA) is fundraising and advocating this awareness month with a "Let Your Light Shine" ...

They may also become more susceptible to other life-threatening conditions such as pulmonary hypertension, chronic ...

Most patients with pulmonary arterial hypertension (PAH) suffered from poor sleep quality, and dyspnea was a significant ...

Each year, 500 to 1,000 people in the United States are diagnosed with pulmonary arterial hypertension (PAH). Because this progressive, chronic disorder is rare, it is often under-detected, causing ...

Received tentative approval from the FDA for YUTREPIATM (treprostinil) inhalation powder for both pulmonary arterial hypertension (PAH) ...

Examples include asthma, chronic obstructive lung disease, cystic fibrosis, pulmonary hypertension and others. Are you interested in participating in clinical trials? Discuss opportunities with your ...

Tectonic Therapeutic's lead candidate TX45 showed positive phase 1 results for Group 2 Pulmonary Hypertension, driving the stock up over 100% in September. TX45 is an Fc-relaxin fusion molecule ...